文献
J-GLOBAL ID:202202246758443691
整理番号:22A0454319
BRD2阻害は宿主細胞受容体ACE2の転写を減少させることによりSARS-CoV-2感染を阻害する【JST・京大機械翻訳】
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
著者 (47件):
Samelson Avi J.
(Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA)
,
Samelson Avi J.
(Chan-Zuckerberg Biohub, San Francisco, CA, USA)
,
Tran Quang Dinh
(Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France)
,
Tran Quang Dinh
(Ecole Doctorale BioSPC, Universite de Paris, Sorbonne Paris Cite, Paris, France)
,
Robinot Remy
(Institut Pasteur, CIVIC Group, Virus and Immunity Unit, Universite de Paris, Paris, France)
,
Carrau Lucia
(Microbiology Department, NYU-Langone, New York, NY, USA)
,
Rezelj Veronica V.
(Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France)
,
Kain Alice Mac
(Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France)
,
Kain Alice Mac
(Ecole Doctorale BioSPC, Universite de Paris, Sorbonne Paris Cite, Paris, France)
,
Chen Merissa
(Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA)
,
Chen Merissa
(Chan-Zuckerberg Biohub, San Francisco, CA, USA)
,
Ramadoss Gokul N.
(Gladstone Institutes, San Francisco, CA, USA)
,
Ramadoss Gokul N.
(Biomedical Sciences PhD Program, University of California San Francisco, San Francisco, CA, USA)
,
Guo Xiaoyan
(Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA)
,
Guo Xiaoyan
(Chan-Zuckerberg Biohub, San Francisco, CA, USA)
,
Lim Shion A.
(Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA)
,
Lim Shion A.
(Department of Antibody Engineering, Genentech Inc., San Francisco, CA, USA)
,
Lui Irene
(Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA)
,
Nunez James K.
(Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA)
,
Nunez James K.
(Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA)
,
Rockwood Sarah J.
(Gladstone Institutes, San Francisco, CA, USA)
,
Wang Jianhui
(School of Medicine, Southern University of Science and Technology, Shenzhen, China)
,
Liu Na
(School of Medicine, Southern University of Science and Technology, Shenzhen, China)
,
Carlson-Stevermer Jared
(Synthego Corporation, Redwood City, CA, USA)
,
Oki Jennifer
(Synthego Corporation, Redwood City, CA, USA)
,
Maures Travis
(Synthego Corporation, Redwood City, CA, USA)
,
Holden Kevin
(Synthego Corporation, Redwood City, CA, USA)
,
Weissman Jonathan S.
(Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA)
,
Weissman Jonathan S.
(Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA, USA)
,
Weissman Jonathan S.
(Whitehead Institute for Biomedical Research, Cambridge, MA, USA)
,
Weissman Jonathan S.
(Department of Biology, Massachusetts Institute of Technology, Cambridge, USA)
,
Wells James A.
(Chan-Zuckerberg Biohub, San Francisco, CA, USA)
,
Wells James A.
(Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA)
,
Wells James A.
(Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA)
,
Conklin Bruce R.
(Gladstone Institutes, San Francisco, CA, USA)
,
Conklin Bruce R.
(Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA)
,
Conklin Bruce R.
(Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA)
,
Conklin Bruce R.
(Department of Medicine, University of California San Francisco, San Francisco, CA, USA)
,
TenOever Benjamin R.
(Microbiology Department, NYU-Langone, New York, NY, USA)
,
Chakrabarti Lisa A.
(Institut Pasteur, CIVIC Group, Virus and Immunity Unit, Universite de Paris, Paris, France)
,
Vignuzzi Marco
(Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France)
,
Tian Ruilin
(Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA)
,
Tian Ruilin
(Chan-Zuckerberg Biohub, San Francisco, CA, USA)
,
Tian Ruilin
(School of Medicine, Southern University of Science and Technology, Shenzhen, China)
,
Kampmann Martin
(Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA)
,
Kampmann Martin
(Chan-Zuckerberg Biohub, San Francisco, CA, USA)
,
Kampmann Martin
(Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA)
資料名:
Nature Cell Biology
(Nature Cell Biology)
巻:
24
号:
1
ページ:
24-34
発行年:
2022年
JST資料番号:
W1369A
ISSN:
1465-7392
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)